Results 1 to 10 of about 1,900,220 (231)

CCKBR (Gastrin Receptor) as a Theranostic Target in Oncology: Biological Rationale, Diagnostic Imaging, and Next-Generation Peptide-Based Drug Development [PDF]

open access: yesPharmaceutics
Cholecystokinin B receptor (CCKBR) is a promising theranostic target because of its overexpression in several malignancies, including medullary thyroid carcinoma, small-cell lung cancer, gastric cancer, and pancreatic cancer.
Ming-Cheng Chang   +4 more
doaj   +2 more sources

Recent advances in radionuclide medical imaging techniques

open access: yesFrontiers in Medicine
Radionuclide imaging combines nuclear technique and medicine through the administration of radioactive drugs into living organisms, followed by imaging with specialized instruments.
Shuyu Xu   +6 more
doaj   +3 more sources

Association of regional cerebral perfusion impairment with gait and balance performance in dizzy patients using brain perfusion SPECT: Voxel-based analysis of a pilot sample [PDF]

open access: yesAsia Oceania Journal of Nuclear Medicine and Biology, 2021
Objective(s): The purpose of this study was to investigate regional cerebral blood flow (rCBF) reduction in patients with dizziness and perfusion-related clinical impairment using brain perfusion single photon emission tomography (SPECT).Methods: Thirty ...
Reza Nemati   +7 more
doaj   +1 more source

Osteopetrosis: radiological & radionuclide imaging.

open access: yesIndian J Nucl Med, 2015
Osteopetrosis is a rare inherited bone disease where bones harden and become abnormally dense. While the diagnosis is clinical, it also greatly relies on appearance of the skeleton radiographically. X-ray, radionuclide bone scintigraphy and magnetic resonance imaging have been reported to identify characteristics of osteopetrosis.
Sit C   +3 more
europepmc   +4 more sources

RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics [PDF]

open access: yesAsia Oceania Journal of Nuclear Medicine and Biology, 2021
A limitation to the wider introduction of personalised dosimetry in theranostics is the relative paucity of imaging radionuclides with suitable physical and chemical properties to be paired with a long-lived therapeutic partner.
Dale Bailey   +5 more
doaj   +1 more source

Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae)

open access: yesScientific Reports, 2021
Other than in animal models of human disease, little functional imaging has been performed in most of the animal world. The aim of this study was to explore the functional anatomy of the European round back slug (Arionidae) and leopard slug (Limacidae ...
Nicola Beindorff   +4 more
doaj   +1 more source

Radiometals in Imaging and Therapy: Highlighting Two Decades of Research

open access: yesPharmaceuticals, 2023
The present article highlights the important progress made in the last two decades in the fields of molecular imaging and radionuclide therapy. Advancements in radiometal-based positron emission tomography, single photon emission computerized tomography,
Shalini Sharma, Mukesh K. Pandey
doaj   +1 more source

Dual-radionuclide in vivo imaging of micro-metastasis and lymph tract with submillimetre resolution

open access: yesScientific Reports, 2023
Multi-radionuclide in vivo imaging with submillimetre resolution can be a potent tool for biomedical research. While high-resolution radionuclide imaging faces challenges in sensitivity, multi-radionuclide imaging encounters difficulty due to radiation ...
Atsushi Yagishita   +6 more
doaj   +1 more source

Radionuclide imaging of neuroendocrine tumors [PDF]

open access: yesMedicinski Podmladak, 2020
Neuroendocrine tumors (NETs) are relatively rare and heterogeneous with a variaty of clinical expression. They derive from the sensory and secretory neuroendocrine cells mainly within the pulmonary and gastrointestinal tract.
Šaponjski Jelena   +2 more
doaj   +1 more source

An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay

open access: yesWorld Journal of Nuclear Medicine, 2020
Prostate-specific membrane antigen (PSMA) is a Type II transmembrane glycoprotein which is extremely overexpressed in prostate cancer epithelial cells. Recently, PSMA-targeted small molecule labeled with 68Ga and 99mTc allowed precise molecular imaging ...
Esmail Jafari   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy